EPIVIR-HBV (lamivudine 100 mg) Patient Assistance Program
Don’t let the high cost of brand chronic hepatitis B therapy disrupt your treatment. We help eligible patients access Epivir-HBV (lamivudine 100 mg) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Epivir-HBV (lamivudine 100 mg tablets) is FDA-approved for the treatment of chronic hepatitis B associated with evidence of HBV replication and active liver disease. The lower 100 mg dose distinguishes it from Epivir (300 mg, for HIV).
- Without assistance, brand Epivir-HBV costs commonly run approximately $250–$400 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Epivir-HBV for a flat $69.95 per month — our advocacy team manages the entire enrollment, refills, and renewal process.
- Generic lamivudine is widely available at very low cost. However, lamivudine is no longer first-line for chronic hepatitis B due to high rates of resistance. Current HBV guidelines prefer tenofovir (Viread/Vemlidy, generic TDF available) and entecavir (generic available) as first-line antiviral therapy due to higher potency and much lower resistance.
What Is Epivir-HBV Prescription Assistance Program?
The Epivir-HBV Prescription Assistance Program is a manufacturer-sponsored initiative that provides Epivir-HBV at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for chronic hepatitis B patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, hepatology/primary care coordination, prior-authorization documentation, and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and annual re-certification.
Pharmacy Price Comparison
- Without assistance, brand Epivir-HBV costs roughly $250–$400/month. Generic lamivudine is much cheaper. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$380 | Save ~$310/mo |
| CVS Pharmacy (brand) | ~$400 | Save ~$330/mo |
| Walmart (brand) | ~$280 | Save ~$210/mo |
| Costco (brand) | ~$260 | Save ~$190/mo |
Generic lamivudine 100 | ~$30 | Already low |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Epivir-HBV Prescription Program?
The Patient Assistance Program is free to apply for and provides Epivir-HBV at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic lamivudine at very low cost — and tenofovir or entecavir generally preferred as first-line HBV therapy — we’ll help your provider determine the best path.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Epivir-HBV:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $250–$400 per month even with the best discoun
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Epivir-HBV assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Epivir-HBV Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured Or Underinsured And Cannot Afford Your Medication
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Epivir-HBV:
Epivir-HBV (lamivudine 100 mg) is an oral nucleoside analog antiviral used for chronic hepatitis B. The 100 mg dose for HBV is lower than the 300 mg dose used for HIV (Epivir). Lamivudine was one of the original HBV antivirals but has been largely replaced as first-line therapy due to high rates of HBV resistance.
How Epivir-HBV Works:
The Hepatitis B virus (HBV) replicates inside liver cells by utilizing a reverse transcriptase enzyme to copy its DNA genome. Lamivudine, a cytidine analog, works by getting phosphorylated inside these liver cells and incorporating itself into the growing viral DNA chain, which effectively terminates elongation and halts replication. However, the major drawback to this process is the rapid emergence of viral resistance, with 70% of patients developing the YMDD mutation in the HBV polymerase after five years of monotherapy. Because of this high resistance rate, current medical guidelines no longer recommend lamivudine as a first-line therapy, preferring alternatives like tenofovir or entecavir instead.
Form and use:
Epivir-HBV is administered orally as a single 100 mg tablet taken once daily, and it can be ingested with or without food. Because managing chronic HBV requires sustained viral suppression to prevent disease progression, treatment is typically a long-term commitment that often requires lifelong therapy for many patients. Additionally, because of how the medication is cleared by the body, a renal dose adjustment is required for patients with impaired kidney function.
Generic availability:
Generic lamivudine is widely available at a very low cost in both 100 mg and 150 mg strengths. Despite its availability, modern chronic HBV treatment guidelines prefer other first-line therapies, such as entecavir and tenofovir disoproxil fumarate (TDF), which is the standard choice for most adults. For patients who present with specific kidney or bone risk factors, tenofovir alafenamide is the preferred selection. Ultimately, lamivudine has lost its status as a first-line recommendation solely due to its high propensity for causing viral resistance.
Warnings:
Epivir-HBV carries a serious boxed warning regarding severe, acute HBV exacerbations that can occur if the medication is discontinued, making strict HBV monitoring mandatory after stopping treatment. Furthermore, the 100 mg dose used for HBV is completely inadequate for treating HIV, meaning mandatory HIV testing is required before initiation to avoid creating subtherapeutic HIV resistance. The medication also carries warnings for dangerous conditions such as lactic acidosis, pancreatitis, and severe hepatomegaly with steatosis. Finally, there is a distinct warning regarding the high likelihood of developing HBV resistance when using this medication as a long-term monotherapy.
FAQ (Frequently Asked Questions)
How Much Does Epivir-HBV Cost Without Insurance?
Brand Epivir-HBV costs approximately $250–$400 per 30-day supply. Generic lamivudine 100 mg is substantially cheaper. Through AffordMyPrescriptions, qualifying patients receive Epivir-HBV at no medication cost — our $69.95 monthly fee covers full advocacy and program management. Most patients find generic lamivudine is the cheaper path.
Why Isn't Lamivudine First-Line For Chronic HBV Anymore?
Lamivudine has high rates of HBV resistance with long-term use — about 70% by year 5. Once resistance develops, lamivudine becomes ineffective and HBV viral load rises. Current HBV guidelines prefer tenofovir or entecavir, which have very low resistance rates (≤1% over 5+ years). For new starts, tenofovir or entecavir is preferred over lamivudine.
Should I Switch From Epivir-HBV To Tenofovir Or Entecavir?
Discuss with your hepatologist. If you’ve been on lamivudine without resistance and HBV is suppressed, continuation is reasonable. If HBV DNA remains detectable or rises (suggesting resistance), switching to tenofovir or adding tenofovir is generally recommended. New patients are typically started on tenofovir or entecavir rather than lamivudine.
Why Do I Need HIV Testing Before Starting?
Lamivudine at 100 mg (HBV dose) is too low to treat HIV adequately. If you have undiagnosed HIV and take Epivir-HBV alone, the HIV could develop lamivudine resistance — limiting future HIV treatment. HIV testing is required before starting to ensure HIV is either absent or fully treated with combination therapy.
Can I Stop Once My HBV Is Undetectable?
No, not without hepatology guidance. Stopping HBV antiviral therapy — even with undetectable HBV DNA — can cause severe acute HBV flares (boxed warning), including liver failure. Most patients require long-term or lifelong therapy.
What If My Application Is Denied?
If denied, we explore alternatives — switching to generic lamivudine (much cheaper), generic entecavir, generic TDF, or Vemlidy (with its own PAP), the manufacturer’s copay program for commercially insured patients, or independent foundations. If we cannot find a path, you won’t be charged our ser
Are There Drug Interactions I Should Know About?
Lamivudine has few significant drug interactions. Avoid concurrent use with HIV products containing higher-dose lamivudine (Epivir 300 mg, Combivir, Trizivir, Epzicom) — combining would result in excessive lamivudine exposure. Trimethoprim/sulfamethoxazole modestly raises lamivudine levels — usually not clinically significant. Tell your prescriber about all medications.
Take Control of Your Medication Costs
If you are struggling with the high cost of Epivir-HBV, our team may be able to help you access assistance programs — or guide you to generic lamivudine or a more potent first-line HBV antiviral. Check your eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.